Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Margaret N. Whitacre"'
Autor:
Yi Jiun Chen, Hua Chen Chang, Shivani Srivastava, John F. Toso, Hailin Feng, Zdenka Haskova, Michael J. Robertson, Zdenka Ludmila Jonak, David Pelloso, Stephen H. Trulli, Margaret N. Whitacre, Larry Voiles, David W. Lewis
Publikováno v:
Cancer Immunology, Immunotherapy. 62:1073-1082
The antitumor activity of monoclonal antibodies is mediated by effector cells, such as natural killer (NK) cells, that express Fc receptors for immunoglobulin. Efficacy of monoclonal antibodies, including the CD20 antibody rituximab, could be improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3268756781270515ee9dbaca2a5dd325
https://doi.org/10.1007/s00262-013-1403-0
https://doi.org/10.1007/s00262-013-1403-0
Autor:
Stephen H. Trulli, Margaret N. Whitacre, Marc Ciucci, Kimberly A. Dede, Zdenka Haskova, John F. Toso, Judithann M. Lee, Zdenka Ludmila Jonak, John R. White
Publikováno v:
British Journal of Haematology. 156:402-404
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2673684e7be40424cc29182cd9cb792
https://doi.org/10.1111/j.1365-2141.2011.08829.x
https://doi.org/10.1111/j.1365-2141.2011.08829.x
Autor:
John F. Toso, Marc Ciucci, John R. White, Kimberly A. Dede, Judithann M. Lee, Margaret N. Whitacre, Zdenka Ludmila Jonak, Zdenka Haskova, Stephen H. Trulli
Publikováno v:
Cancer Research. 70:LB-317
Ofatumumab (OFA) is a fully human CD20 monoclonal antibody (mAb) recently approved for treatment of patients with fludarabine- and alemtuzumab-refractory chronic lymphocytic leukemia (CLL). OFA binds a unique membrane-proximal epitope encompassing bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ff7ae8d1f2157ab06f43090029072f7
https://doi.org/10.1158/1538-7445.am10-lb-317
https://doi.org/10.1158/1538-7445.am10-lb-317